AMZ
AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE
Created: | 2002-08-15 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 37 |
Chiral Atom Count | 4 |
Bond Count | 38 |
Aromatic Bond Count | 5 |
Chemical Component Summary | |
---|---|
Name | AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE |
Synonyms | AICAR |
Systematic Name (OpenEye OEToolkits) | [(2R,3S,4R,5R)-5-(5-amino-4-aminocarbonyl-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate |
Formula | C9 H15 N4 O8 P |
Molecular Weight | 338.211 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(c1ncn(c1N)C2OC(C(O)C2O)COP(=O)(O)O)N |
SMILES | CACTVS | 3.341 | NC(=O)c1ncn([CH]2O[CH](CO[P](O)(O)=O)[CH](O)[CH]2O)c1N |
SMILES | OpenEye OEToolkits | 1.5.0 | c1nc(c(n1C2C(C(C(O2)COP(=O)(O)O)O)O)N)C(=O)N |
Canonical SMILES | CACTVS | 3.341 | NC(=O)c1ncn([C@@H]2O[C@H](CO[P](O)(O)=O)[C@@H](O)[C@H]2O)c1N |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | c1nc(c(n1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N |
InChI | InChI | 1.03 | InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/t3-,5-,6-,9-/m1/s1 |
InChIKey | InChI | 1.03 | NOTGFIUVDGNKRI-UUOKFMHZSA-N |
Drug Info: DrugBank
DrugBank ID | DB01700 |
---|---|
Name | AICA ribonucleotide |
Groups |
|
Description | 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an intermediate in the generation of inosine monophosphate and analog of adenosine monophosphate (AMP) that is capable of stimulating AMP-dependent protein kinase (AMPK) activity. AICAR has been used clinically to treat and protect against cardiac ischemic injury. The drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery and is currently of interest as a potential treatment for diabetes by increasing the metabolic activity of tissues by changing the physical composition of muscle. |
Synonyms |
|
Categories |
|
CAS number | 3031-94-5 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Bifunctional purine biosynthesis protein PURH | MAPGQLALFSVSDKTGLVEFARNLTALGLNLVASGGTAKALRDAGLAVRD... | unknown |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 65110 |
ChEMBL | CHEMBL483849 |
ChEBI | CHEBI:18406 |